Market Scenario
Global Research Antibodies Market was valued US$ 105Bn in 2017 and is anticipated to reach US$ 9.34Bn by 2026 at a CAGR of about 7.06% during a forecast.
Global Research Antibodies Market scope is divided by Product type, by Antibody Clonality, by Antibody Source, by Technology, by Application, by End User and by region. Based on Product Type Research Antibodies Market is segmented into Primary & Secondary. By Antibody Clonality are segmented in Monoclonal antibody, Polyclonal antibody & Oligo clonal antibody. By Antibody Source are segmented in Mouse, Rabbit & Others, By Technology are segmented in to Western Blotting, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Immunohistochemistry, Immunofluorescence, Immunoprecipitation & Others. By Application are segmented in Infectious Diseases, Immunology, Oncology, Stem Cells, neurobiology & others. By End User are segmented in Pharmaceutical & Biotechnological Companies, Academic & Research Institutes & Contract Research Organizations. Geographically into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Global Research Antibodies Market
The driving factors for the Research Antibodies Market are Increasing Research and development activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, increasing prevalence of cancer and other chronic diseases with increasing healthcare expenditure, growing population, increasing urbanization & industrialization and various government authorities are supporting this R&D growth by providing funding and reducing approval time for new drug molecules.
Poor quality products offered by local vendors and investment of huge money and time in the antibody development process can hamper the growth of Research Antibodies Market.
In terms of Antibody Clonality, Monoclonal antibody segment are in leading share of the market in forecast period. Monoclonal antibodies are cheaper to develop than conventional drugs because it is based on tested technology, Side effects can be treated and reduced by using mice-human hybrid cells or by using fractions of antibodies and most useful for bind to specific diseased or damaged cells needing treatment are factor for growth in market. In Technology, Western blotting is segment accounted for the largest share of the research antibodies market. One of the biggest in favour of western blot is its sensitivity and its ability to detect as little as 0.1 mammograms of protein in a sample, the technique can theoretically serve as an effective early diagnostic tool, sensing even the slightest immunogenic response from a virus or bacteria in a patient sample and widely used in research activities conducted by academic institutes as well as pharmaceutical and biotechnology companies.
In terms of application segment, proteomics will hold the largest market during the forecast period. The upsurge in proteomics research is attributed to the rising need for designing more effective drugs through protein based disease profiling, growing demand for personalized & protein therapeutics, and increasing public & private sector spending on proteomics research. In end User, Pharmaceutical & Biotechnological Companies held the largest market share in 2016. Market owing to the high uptake of research-specific antibodies in the drug discovery and development process, along with the increasing use of these research tools in the ever-developing proteomics research sector.
Among region, Asia Pacific is expected to grow at the highest CAGR during the forecast period. This regional segment shows significant market growth opportunities owing to proteomics and genomics research & increasing research funding, rising economics, rising population, increasing investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics.
Abcam PLC, Active Motif, Affinity Biologicals Inc., Becton Dickinson and Company, Bethyl Laboratories Inc., Biolegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Danaher Corporation, Enzo Life Sciences Inc., F. Hoffmann-La Roche Ltd, Genscript, Jackson Immunoresearch Inc., Lonza, Merck Group, Miltenyl Biotec, Origene Technologies Inc., Perkinelmer Inc., Qiagen N.V., Rockland Immunochemicals Inc., Sysmex Corporation, Thermo Fisher Scientific Inc.
Scope of the Global Research Antibodies Market:
Global Research Antibodies Market: By Product Type
• Primary
• Secondary
Global Research Antibodies Market: By Antibody Clonality
• Monoclonal antibody
• Polyclonal antibody
• Oligo clonal antibody
Global Research Antibodies Market: By Antibody Source
• Mouse
• Rabbit
• Others
Global Research Antibodies Market: By Technology
• Western Blotting
• Flow Cytometry
• Enzyme-linked Immunosorbent Assay
• Immunohistochemistry
• Immunofluorescence
• Immunoprecipitation
• Others
Global Research Antibodies Market: By Application
• Proteomics
• Infectious Diseases
• Immunology
• Oncology
• Stem Cells
• Neurobiology
• Others
Global Research Antibodies Market: By End User
• Pharmaceutical & Biotechnological Companies
• Academic & Research Institutes
• Contract Research Organizations
Global Research Antibodies Market: By region
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
Key Player analysed in the Global Research Antibodies Market:
• Abcam PLC
• Active Motif
• Affinity Biologicals Inc.
• Becton Dickinson and Company
• Bethyl Laboratories Inc.
• Biolegend Inc.
• Bio-Rad Laboratories Inc.
• Cell Signaling Technology Inc.
• Danaher Corporation
• Enzo Life Sciences Inc.
• F. Hoffmann-La Roche Ltd
• Genscript
• Jackson Immunoresearch Inc.
• Lonza
• Merck Group
• Miltenyl Biotec
• Origene Technologies Inc.
• Perkinelmer Inc.
• Qiagen N.V.
• Rockland Immunochemicals Inc.
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
Table of Contents
Global Research Antibodies Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
1.4. Key Questions Answered
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Research Antibodies Market Size, By Market Value (US$ Mn) and Market , By Region
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Porter’s Analysis
4.3.5. Value Chain Analysis
4.3.6. SWOT Analysis
5. Global Research Antibodies Market Analysis and Forecast
5.1. Global Research Antibodies Market Analysis and Forecast
5.2. Global Research Antibodies Market Size & Y-o-Y Growth Analysis
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Middle East & Africa
5.2.5. Latin America
6. Global Research Antibodies Market Analysis and Forecast, By Product Type
6.1. Introduction and Definition
6.2. Key Findings
6.3. Global Research Antibodies Market Value Share Analysis, By Product type
6.4. Global Research Antibodies Market Size (US$ Mn) Forecast, By Product type
6.5. Global Research Antibodies Market Analysis, By Product type
6.6. Global Research Antibodies Market Attractiveness Analysis, By Product type
7. Global Research Antibodies Market Analysis and Forecast, By Antibody Clonality
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Research Antibodies Market Value Share Analysis, By Antibody Clonality
7.4. Global Research Antibodies Market Size (US$ Mn) Forecast, By Antibody Clonality
7.5. Global Research Antibodies Market Analysis, By Antibody Clonality
7.6. Global Research Antibodies Market Attractiveness Analysis, By Antibody Clonality
8. Global Research Antibodies Market Analysis and Forecast, By Antibody Source
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Research Antibodies Market Value Share Analysis, By Antibody Source
8.4. Global Research Antibodies Market Size (US$ Mn) Forecast, By Antibody Source
8.5. Global Research Antibodies Market Analysis, By Antibody Source
8.6. Global Research Antibodies Market Attractiveness Analysis, By Antibody Source
9. Global Research Antibodies Market Analysis and Forecast, By Technology
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Research Antibodies Market Value Share Analysis, By Technology
9.4. Global Research Antibodies Market Size (US$ Mn) Forecast, By Technology
9.5. Global Research Antibodies Market Analysis, By Technology
9.6. Global Research Antibodies Market Attractiveness Analysis, By Technology
10. Global Research Antibodies Market Analysis and Forecast, By Application
10.1. Introduction and Definition
10.2. Key Findings
10.3. Global Research Antibodies Market Value Share Analysis, By Application
10.4. Global Research Antibodies Market Size (US$ Mn) Forecast, By Application
10.5. Global Research Antibodies Market Analysis, By Application
10.6. Global Research Antibodies Market Attractiveness Analysis, By Application
11. Global Research Antibodies Market Analysis and Forecast, By End User
11.1. Introduction and Definition
11.2. Key Findings
11.3. Global Research Antibodies Market Value Share Analysis, By End User
11.4. Global Research Antibodies Market Size (US$ Mn) Forecast, By End User
11.5. Global Research Antibodies Market Analysis, By End User
11.6. Global Research Antibodies Market Attractiveness Analysis, By End User
12. Global Research Antibodies Market Analysis, By Region
12.1. Key Findings
12.2. Global Research Antibodies Market Value Share Analysis, By Region
12.3. Global Research Antibodies Market Size (US$ Mn) Forecast, By Region
12.4. Global Research Antibodies Market Analysis, By Region
12.5. Global Research Antibodies Market Attractiveness Analysis, By Region
13. North America Research Antibodies Market Analysis
13.1. North America Research Antibodies Market Overview
13.2. North America Research Antibodies Market Value Share Analysis, By Product type
13.3. North America Research Antibodies Market Forecast, By Product type
13.3.1. Primary
13.3.2. Secondary
13.4. North America Research Antibodies Market Value Share Analysis, By Antibody Source Antibody Clonality
13.5. North America Research Antibodies Market Forecast, By Antibody Source Antibody Clonality
13.5.1. Monoclonal Antibody
13.5.2. Polyclonal Antibody
13.5.3. Oligoclonal antibody
13.6. North America Research Antibodies Market Value Share Analysis, By Antibody Clonality
13.7. North America Research Antibodies Market Forecast, By Antibody Clonality
13.7.1. Mouse
13.7.2. Rabbit
13.7.3. Others
13.8. North America Research Antibodies Market Value Share Analysis, By Technology
13.9. North America Research Antibodies Market Forecast, By Technology
13.9.1. Western Blotting
13.9.2. Flow Cytometry
13.9.3. Enzyme-linked Immunosorbent Assay
13.9.4. Immunohistochemistry
13.9.5. Immunofluorescence
13.9.6. Immunoprecipitation
13.9.7. Others
13.10. North America Research Antibodies Market Value Share Analysis, By Application
13.11. North America Research Antibodies Market Forecast, By Application
13.11.1. Proteomics
13.11.2. Infectious Diseases
13.11.3. Immunology
13.11.4. Oncology
13.11.5. Stem Cells
13.11.6. Neurobiology
13.11.7. Others
13.12. North America Research Antibodies Market Value Share Analysis, By End User
13.13. North America Research Antibodies Market Forecast, By End User
13.13.1. Pharmaceutical & Biotechnological Companies
13.13.2. Academic & Research Institutes
13.13.3. Contract Research Organizations
Others
13.14. North America Research Antibodies Market Value Share Analysis, By Country
13.15. North America Research Antibodies Market Forecast, By Country
13.15.1.1. U.S.
13.15.1.2. Canada.
13.16. U.S. Research Antibodies Market Forecast, By Product type
13.16.1. Primary
13.16.2. Secondary
13.17. U.S. Research Antibodies Market Forecast, By Antibody Source
13.17.1. Monoclonal Antibody
13.17.2. Polyclonal Antibody
13.17.3. Oligoclonal antibody
13.18. U.S. Research Antibodies Market Forecast, By Antibody Clonality
13.18.1. Mouse
13.18.2. Rabbit
13.18.3. Others
13.19. U.S. Research Antibodies Market Forecast, By Technology
13.19.1. Western Blotting
13.19.2. Flow Cytometry
13.19.3. Enzyme-linked Immunosorbent Assay
13.19.4. Immunohistochemistry
13.19.5. Immunofluorescence
13.19.6. Immunoprecipitation
13.19.7. Others
13.20. U.S. Research Antibodies Market Forecast, By Application
13.20.1. Proteomics
13.20.2. Infectious Diseases
13.20.3. Immunology
13.20.4. Oncology
13.20.5. Stem Cells
13.20.6. Neurobiology
13.20.7. Others
13.21. U.S. Research Antibodies Market Forecast, By End User
13.21.1. Pharmaceutical & Biotechnological Companies
13.21.2. Academic & Research Institutes
13.21.3. Contract Research Organizations
13.22. Canada Research Antibodies Market Forecast, By Product type
13.22.1. Primary
13.22.2. Secondary
13.23. Canada Research Antibodies Market Forecast, By Antibody Source
13.23.1. Monoclonal Antibody
13.23.2. Polyclonal Antibody
13.23.3. Oligoclonal antibody
13.24. Canada Research Antibodies Market Forecast, By Antibody Clonality
13.24.1. Mouse
13.24.2. Rabbit
13.24.3. Others
13.25. Canada Research Antibodies Market Forecast, By Technology
13.25.1. Western Blotting
13.25.2. Flow Cytometry
13.25.3. Enzyme-linked Immunosorbent Assay
13.25.4. Immunohistochemistry
13.25.5. Immunofluorescence
13.25.6. Immunoprecipitation
13.25.7. Others
13.26. Canada Research Antibodies Market Forecast, By Application
13.26.1. Proteomics
13.26.2. Infectious Diseases
13.26.3. Immunology
13.26.4. Oncology
13.26.5. Stem Cells
13.26.6. Neurobiology
13.26.7. Others
13.27. Canada Research Antibodies Market Forecast, By End User
13.27.1. Pharmaceutical & Biotechnological Companies
13.27.2. Academic & Research Institutes
13.27.3. Contract Research Organizations
13.28. North America Research Antibodies Market Attractiveness Analysis
13.28.1. By Product type
13.28.2. By Antibody Clonality
13.28.3. By Antibody Source
13.28.4. By Technology
13.28.5. By Application
13.28.6. By End User
13.29. PEST Analysis
14. Europe Global Research Antibodies Market Analysis
14.1. Key Findings
14.2. Europe Research Antibodies Market Overview
14.3. Europe Research Antibodies Market Value Share Analysis, By Product type
14.4. Europe Research Antibodies Market Forecast, By Product type
14.4.1. Primary
14.4.2. Secondary
14.5. Europe Research Antibodies Market Value Share Analysis, By Antibody Source
14.6. Europe Research Antibodies Market Forecast, By Antibody Source
14.6.1. Monoclonal Antibody
14.6.2. Polyclonal Antibody
14.6.3. Oligoclonal antibody
14.7. Europe Research Antibodies Market Value Share Analysis, By Antibody Clonality
14.8. Europe Research Antibodies Market Forecast, By Antibody Clonality
14.8.1. Mouse
14.8.2. Rabbit
14.8.3. Others
14.9. Europe Research Antibodies Market Value Share Analysis, By Technology
14.10. Europe Research Antibodies Market Forecast, By Technology
14.10.1. Western Blotting
14.10.2. Flow Cytometry
14.10.3. Enzyme-linked Immunosorbent Assay
14.10.4. Immunohistochemistry
14.10.5. Immunofluorescence
14.10.6. Immunoprecipitation
14.10.7. Others
14.11. Europe Research Antibodies Market Forecast, By Application
14.11.1. Proteomics
14.11.2. Infectious Diseases
14.11.3. Immunology
14.11.4. Oncology
14.11.5. Stem Cells
14.11.6. Neurobiology
14.11.7. Others
14.12. Europe Research Antibodies Market Forecast, By End User
14.12.1. Pharmaceutical & Biotechnological Companies
14.12.2. Academic & Research Institutes
14.12.3. Contract Research Organizations
14.13. Europe Research Antibodies Market Forecast, By Country
14.13.1. Germany
14.13.2. U.K.
14.13.3. France
14.13.4. Italy
14.13.5. Spain
14.13.6. Rest of Europe
14.14. Europe Research Antibodies Market Analysis, By Country/ Sub-region
14.15. Germany Research Antibodies Market Forecast, By Product type
14.15.1. Primary
14.15.2. Secondary
14.16. Germany Research Antibodies Market Forecast, By Antibody Source
14.16.1. Monoclonal Antibody
14.16.2. Polyclonal Antibody
14.16.3. Oligoclonal antibody
14.17. Germany Research Antibodies Market Forecast, By Antibody Clonality
14.17.1. Mouse
14.17.2. Rabbit
14.17.3. Others
14.18. Germany Research Antibodies Market Forecast, By Technology
14.18.1. Western Blotting
14.18.2. Flow Cytometry
14.18.3. Enzyme-linked Immunosorbent Assay
14.18.4. Immunohistochemistry
14.18.5. Immunofluorescence
14.18.6. Immunoprecipitation
14.18.7. Others
14.19. Germany Research Antibodies Market Forecast, By Application
14.19.1. Proteomics
14.19.2. Infectious Diseases
14.19.3. Immunology
14.19.4. Oncology
14.19.5. Stem Cells
14.19.6. Neurobiology
14.19.7. Others
14.20. Germany Research Antibodies Market Forecast, By End User
14.20.1. Pharmaceutical & Biotechnological Companies
14.20.2. Academic & Research Institutes
14.20.3. Contract Research Organizations
14.21. U.K Research Antibodies Market Forecast, By Product type
14.21.1. Primary
14.21.2. Secondary
14.22. U.K Research Antibodies Market Forecast, By Antibody Source
14.22.1. Monoclonal Antibody
14.22.2. Polyclonal Antibody
14.22.3. Oligoclonal antibody
14.23. U.K Research Antibodies Market Forecast, By Antibody Clonality
14.23.1. Mouse
14.23.2. Rabbit
14.23.3. Others
14.24. U.K Research Antibodies Market Forecast, By Technology
14.24.1. Western Blotting
14.24.2. Flow Cytometry
14.24.3. Enzyme-linked Immunosorbent Assay
14.24.4. Immunohistochemistry
14.24.5. Immunofluorescence
14.24.6. Immunoprecipitation
14.24.7. Others
14.25. U.K Research Antibodies Market Forecast, By Application
14.25.1. Proteomics
14.25.2. Infectious Diseases
14.25.3. Immunology
14.25.4. Oncology
14.25.5. Stem Cells
14.25.6. Neurobiology
14.25.7. Others
14.26. U.K Research Antibodies Market Forecast, By End User
14.26.1. Pharmaceutical & Biotechnological Companies
14.26.2. Academic & Research Institutes
14.26.3. Contract Research Organizations
14.27. France Research Antibodies Market Forecast, By Product type
14.27.1. Primary
14.27.2. Secondary
14.28. France Research Antibodies Market Forecast, By Antibody Source
14.28.1. Monoclonal Antibody
14.28.2. Polyclonal Antibody
14.28.3. Oligoclonal antibody
14.29. France Research Antibodies Market Forecast, By Antibody Clonality
14.29.1. Mouse
14.29.2. Rabbit
14.29.3. Others
14.30. France Research Antibodies Market Forecast, By Technology
14.30.1. Western Blotting
14.30.2. Flow Cytometry
14.30.3. Enzyme-linked Immunosorbent Assay
14.30.4. Immunohistochemistry
14.30.5. Immunofluorescence
14.30.6. Immunoprecipitation
14.30.7. Others
14.31. France Research Antibodies Market Forecast, By Application
14.31.1. Proteomics
14.31.2. Infectious Diseases
14.31.3. Immunology
14.31.4. Oncology
14.31.5. Stem Cells
14.31.6. Neurobiology
14.31.7. Others
14.32. France Research Antibodies Market Forecast, By End User
14.32.1. Pharmaceutical & Biotechnological Companies
14.32.2. Academic & Research Institutes
14.32.3. Contract Research Organizations
14.33. Italy Research Antibodies Market Forecast, By Product type
14.33.1. Primary
14.33.2. Secondary
14.34. Italy Research Antibodies Market Forecast, By Antibody Source
14.34.1. Monoclonal Antibody
14.34.2. Polyclonal Antibody
14.34.3. Oligoclonal antibody
14.35. Italy Research Antibodies Market Forecast, By Antibody Clonality
14.35.1. Mouse
14.35.2. Rabbit
14.35.3. Others
14.36. Italy Research Antibodies Market Forecast, By Technology
14.36.1. Western Blotting
14.36.2. Flow Cytometry
14.36.3. Enzyme-linked Immunosorbent Assay
14.36.4. Immunohistochemistry
14.36.5. Immunofluorescence
14.36.6. Immunoprecipitation
14.36.7. Others
14.37. Italy Research Antibodies Market Forecast, By Application
14.37.1. Proteomics
14.37.2. Infectious Diseases
14.37.3. Immunology
14.37.4. Oncology
14.37.5. Stem Cells
14.37.6. Neurobiology
14.37.7. Others
14.38. Italy Research Antibodies Market Forecast, By End User
14.38.1. Pharmaceutical & Biotechnological Companies
14.38.2. Academic & Research Institutes
14.38.3. Contract Research Organizations
14.39. Spain Research Antibodies Market Forecast, By Product type
14.39.1. Primary
14.39.2. Secondary
14.40. Spain Research Antibodies Market Forecast, By Antibody Source
14.40.1. Monoclonal Antibody
14.40.2. Polyclonal Antibody
14.40.3. Oligoclonal antibody
14.41. Spain Research Antibodies Market Forecast, By Antibody Clonality
14.41.1. Mouse
14.41.2. Rabbit
14.41.3. Others
14.42. Spain Research Antibodies Market Forecast, By Technology
14.42.1. Western Blotting
14.42.2. Flow Cytometry
14.42.3. Enzyme-linked Immunosorbent Assay
14.42.4. Immunohistochemistry
14.42.5. Immunofluorescence
14.42.6. Immunoprecipitation
14.42.7. Others
14.43. Spain Research Antibodies Market Forecast, By Application
14.43.1. Proteomics
14.43.2. Infectious Diseases
14.43.3. Immunology
14.43.4. Oncology
14.43.5. Stem Cells
14.43.6. Neurobiology
14.43.7. Others
14.44. Spain Research Antibodies Market Forecast, By End User
14.44.1. Pharmaceutical & Biotechnological Companies
14.44.2. Academic & Research Institutes
14.44.3. Contract Research Organizations
14.45. Rest of Europe Research Antibodies Market Forecast, By Product type
14.45.1. Primary
14.45.2. Secondary
14.46. Rest of Europe Research Antibodies Market Forecast, By Antibody Source
14.46.1. Monoclonal Antibody
14.46.2. Polyclonal Antibody
14.46.3. Oligoclonal antibody
14.47. Rest of Europe Research Antibodies Market Forecast, By Antibody Clonality
14.47.1. Mouse
14.47.2. Rabbit
14.47.3. Others
14.48. Rest of Europe Research Antibodies Market Forecast, By Technology
14.48.1. Western Blotting
14.48.2. Flow Cytometry
14.48.3. Enzyme-linked Immunosorbent Assay
14.48.4. Immunohistochemistry
14.48.5. Immunofluorescence
14.48.6. Immunoprecipitation
14.48.7. Others
14.49. Rest of Europe Research Antibodies Market Forecast, By Application
14.49.1. Proteomics
14.49.2. Infectious Diseases
14.49.3. Immunology
14.49.4. Oncology
14.49.5. Stem Cells
14.49.6. Neurobiology
14.49.7. Others
14.50. Rest of Europe Research Antibodies Market Forecast, By End User
14.50.1. Pharmaceutical & Biotechnological Companies
14.50.2. Academic & Research Institutes
14.50.3. Contract Research Organizations
14.51. Europe Research Antibodies Market Attractiveness Analysis
14.51.1. By Product type
14.51.2. By Antibody Clonality
14.51.3. By Antibody Source
14.51.4. By Technology
14.51.5. By Application
14.51.6. By End User
14.52. PEST Analysis
15. Asia Pacific Global Research Antibodies Market Analysis
15.1. Key Findings
15.2. Asia Pacific Research Antibodies Market Overview
15.3. Asia Pacific Research Antibodies Market Value Share Analysis, By Product type
15.4. Asia Pacific Research Antibodies Market Forecast, By Product type
15.4.1. Primary
15.4.2. Secondary
15.5. Asia Pacific Research Antibodies Market Value Share Analysis, By Antibody Source
15.6. Asia Pacific Research Antibodies Market Forecast, By Antibody Source
15.6.1. Monoclonal Antibody
15.6.2. Polyclonal Antibody
15.6.3. Oligoclonal antibody
15.7. Asia Pacific Research Antibodies Market Value Share Analysis, By Antibody Clonality
15.8. Asia Pacific Research Antibodies Market Forecast, By Antibody Clonality
15.8.1. Mouse
15.8.2. Rabbit
15.8.3. Others
15.9. Asia Pacific Research Antibodies Market Value Share Analysis, By Technology
15.10. Asia Pacific Research Antibodies Market Forecast, By Technology
15.10.1. Western Blotting
15.10.2. Flow Cytometry
15.10.3. Enzyme-linked Immunosorbent Assay
15.10.4. Immunohistochemistry
15.10.5. Immunofluorescence
15.10.6. Immunoprecipitation
15.10.7. Others
15.11. Asia Pacific Research Antibodies Market Value Share Analysis, By Application
15.12. Asia Pacific Research Antibodies Market Forecast, By Application
15.12.1. Proteomics
15.12.2. Infectious Diseases
15.12.3. Immunology
15.12.4. Oncology
15.12.5. Stem Cells
15.12.6. Neurobiology
15.12.7. Others
15.13. Asia Pacific Research Antibodies Market Value Share Analysis, By End User
15.14. Asia Pacific Research Antibodies Market Forecast, By End User
15.14.1. Pharmaceutical & Biotechnological Companies
15.14.2. Academic & Research Institutes
15.14.3. Contract Research Organizations
15.15. Asia Pacific Research Antibodies Market Value Share Analysis, By Country
15.16. Asia Pacific Research Antibodies Market Forecast, By Country
15.16.1. China.
15.16.2. India.
15.16.3. Japan.
15.16.4. ASEAN.
15.16.5. Rest of Asia Pacific.
15.17. Asia Pacific Research Antibodies Market Analysis, By Country/ Sub-region
15.18. China Research Antibodies Market Forecast, By Product type
15.18.1. Primary
15.18.2. Secondary
15.19. China Research Antibodies Market Forecast, By Antibody Source
15.19.1. Monoclonal Antibody
15.19.2. Polyclonal Antibody
15.19.3. Oligoclonal antibody
15.20. China Research Antibodies Market Forecast, By Antibody Clonality
15.20.1. Mouse
15.20.2. Rabbit
15.20.3. Others
15.21. China Research Antibodies Market Forecast, By Technology
15.21.1. Western Blotting
15.21.2. Flow Cytometry
15.21.3. Enzyme-linked Immunosorbent Assay
15.21.4. Immunohistochemistry
15.21.5. Immunofluorescence
15.21.6. Immunoprecipitation
15.21.7. Others
15.22. China Research Antibodies Market Forecast, By Application
15.22.1. Proteomics
15.22.2. Infectious Diseases
15.22.3. Immunology
15.22.4. Oncology
15.22.5. Stem Cells
15.22.6. Neurobiology
15.22.7. Others
15.23. China Research Antibodies Market Forecast, By End User
15.23.1. Pharmaceutical & Biotechnological Companies
15.23.2. Academic & Research Institutes
15.23.3. Contract Research Organizations
15.24. India Research Antibodies Market Forecast, By Product type
15.24.1. Primary
15.24.2. Secondary
15.25. India Research Antibodies Market Forecast, By Antibody Source
15.25.1. Monoclonal Antibody
15.25.2. Polyclonal Antibody
15.25.3. Oligoclonal antibody
15.26. India Research Antibodies Market Forecast, By Antibody Clonality
15.26.1. Mouse
15.26.2. Rabbit
15.26.3. Others
15.27. India Research Antibodies Market Forecast, By Technology
15.27.1. Western Blotting
15.27.2. Flow Cytometry
15.27.3. Enzyme-linked Immunosorbent Assay
15.27.4. Immunohistochemistry
15.27.5. Immunofluorescence
15.27.6. Immunoprecipitation
15.27.7. Others
15.28. India Research Antibodies Market Forecast, By Application
15.28.1. Proteomics
15.28.2. Infectious Diseases
15.28.3. Immunology
15.28.4. Oncology
15.28.5. Stem Cells
15.28.6. Neurobiology
15.28.7. Others
15.29. India Research Antibodies Market Forecast, By End User
15.29.1. Pharmaceutical & Biotechnological Companies
15.29.2. Academic & Research Institutes
15.29.3. Contract Research Organizations
15.30. Japan Research Antibodies Market Forecast, By Product type
15.30.1. Primary
15.30.2. Secondary
15.31. Japan Research Antibodies Market Forecast, By Antibody Source
15.31.1. Monoclonal Antibody
15.31.2. Polyclonal Antibody
15.31.3. Oligoclonal antibody
15.32. Japan Research Antibodies Market Forecast, By Antibody Clonality
15.32.1. Mouse
15.32.2. Rabbit
15.32.3. Others
15.33. Japan Research Antibodies Market Forecast, By Technology
15.33.1. Western Blotting
15.33.2. Flow Cytometry
15.33.3. Enzyme-linked Immunosorbent Assay
15.33.4. Immunohistochemistry
15.33.5. Immunofluorescence
15.33.6. Immunoprecipitation
15.33.7. Others
15.34. Japan Research Antibodies Market Forecast, By Application
15.34.1. Proteomics
15.34.2. Infectious Diseases
15.34.3. Immunology
15.34.4. Oncology
15.34.5. Stem Cells
15.34.6. Neurobiology
15.34.7. Others
15.35. Japan Research Antibodies Market Forecast, By End User
15.35.1. Pharmaceutical & Biotechnological Companies
15.35.2. Academic & Research Institutes
15.35.3. Contract Research Organizations
15.36. ASEAN Research Antibodies Market Forecast, By Product type
15.36.1. Primary
15.36.2. Secondary
15.37. ASEAN Research Antibodies Market Forecast, By Antibody Source
15.37.1. Monoclonal Antibody
15.37.2. Polyclonal Antibody
15.37.3. Oligoclonal antibody
15.38. ASEAN Research Antibodies Market Forecast, By Antibody Clonality
15.38.1. Mouse
15.38.2. Rabbit
15.38.3. Others
15.39. ASEAN Research Antibodies Market Forecast, By Technology
15.39.1. Western Blotting
15.39.2. Flow Cytometry
15.39.3. Enzyme-linked Immunosorbent Assay
15.39.4. Immunohistochemistry
15.39.5. Immunofluorescence
15.39.6. Immunoprecipitation
15.39.7. Others
15.40. ASEAN Research Antibodies Market Forecast, By Application
15.40.1. Proteomics
15.40.2. Infectious Diseases
15.40.3. Immunology
15.40.4. Oncology
15.40.5. Stem Cells
15.40.6. Neurobiology
15.40.7. Others
15.41. ASEAN Research Antibodies Market Forecast, By End User
15.41.1. Pharmaceutical & Biotechnological Companies
15.41.2. Academic & Research Institutes
15.41.3. Contract Research Organizations
15.42. ASEAN Research Antibodies Market Forecast, By Product type
15.42.1. Primary
15.42.2. Secondary
15.43. ASEAN Research Antibodies Market Forecast, By Antibody Source
15.43.1. Monoclonal Antibody
15.43.2. Polyclonal Antibody
15.43.3. Oligoclonal antibody
15.44. ASEAN Research Antibodies Market Forecast, By Antibody Clonality
15.44.1. Mouse
15.44.2. Rabbit
15.44.3. Others
15.45. ASEAN Research Antibodies Market Forecast, By Technology
15.45.1. Western Blotting
15.45.2. Flow Cytometry
15.45.3. Enzyme-linked Immunosorbent Assay
15.45.4. Immunohistochemistry
15.45.5. Immunofluorescence
15.45.6. Immunoprecipitation
15.45.7. Others
15.46. ASEAN Research Antibodies Market Forecast, By Application
15.46.1. Proteomics
15.46.2. Infectious Diseases
15.46.3. Immunology
15.46.4. Oncology
15.46.5. Stem Cells
15.46.6. Neurobiology
15.46.7. Others
15.47. ASEAN Research Antibodies Market Forecast, By End User
15.47.1. Pharmaceutical & Biotechnological Companies
15.47.2. Academic & Research Institutes
15.47.3. Contract Research Organizations
15.48. Asia Pacific Research Antibodies Market Attractiveness Analysis
15.48.1. By Product type
15.48.2. By Antibody Clonality
15.48.3. By Antibody Source
15.48.4. By Technology
15.48.5. By Application
15.48.6. By End User
15.49 PEST Analysis
16. Middle East & Africa Research Antibodies Market Analysis
16.1. Key Findings
16.2. Middle East & Africa Research Antibodies Market Overview
16.3. Middle East & Africa Research Antibodies Market Value Share Analysis, By Product type
16.4. Middle East & Africa Research Antibodies Market Forecast, By Product type
16.4.1. Primary
16.4.2. Secondary
16.5. Middle East & Africa Research Antibodies Market Value Share Analysis, By Antibody Source
16.6. Middle East & Africa Research Antibodies Market Forecast, By Antibody Source
16.6.1. Monoclonal Antibody
16.6.2. Polyclonal Antibody
16.6.3. Oligoclonal antibody
16.7. Middle East & Africa Global Research Antibodies Market Value Share Analysis, By Antibody Clonality
16.8. Middle East & Africa Research Antibodies Market Forecast, By Antibody Clonality
16.8.1. Mouse
16.8.2. Rabbit
16.8.3. Others
16.9. Middle East & Africa Research Antibodies Market Value Share Analysis, By Technology
16.10. Middle East & Africa Research Antibodies Market Forecast, By Technology
16.10.1. Western Blotting
16.10.2. Flow Cytometry
16.10.3. Enzyme-linked Immunosorbent Assay
16.10.4. Immunohistochemistry
16.10.5. Immunofluorescence
16.10.6. Immunoprecipitation
16.10.7. Others
16.11. Middle East & Africa Research Antibodies Market Value Share Analysis, By Application
16.12. Middle East & Africa Research Antibodies Market Forecast, By Application
16.12.1. Proteomics
16.12.2. Infectious Diseases
16.12.3. Immunology
16.12.4. Oncology
16.12.5. Stem Cells
16.12.6. Neurobiology
16.12.7. Others
16.13. Middle East & Africa Research Antibodies Market Value Share Analysis, By End User
16.14. Middle East & Africa Research Antibodies Market Forecast, By End User
16.14.1. Pharmaceutical & Biotechnological Companies
16.14.2. Academic & Research Institutes
16.14.3. Contract Research Organizations
16.15. Middle East & Africa Research Antibodies Market Value Share Analysis, By Country
16.16. Middle East & Africa Research Antibodies Market Forecast, By Country
16.16.1. GCC.
16.16.2. South Africa.
16.16.3. Rest of Middle East & Africa.
16.17. Middle East & Africa Research Antibodies Market Analysis, By Country/ Sub-region
16.18. GCC Research Antibodies Market Forecast, By Product type
16.18.1. Primary
16.18.2. Secondary
16.19. GCC Research Antibodies Market Forecast, By Antibody Source
16.19.1. Monoclonal Antibody
16.19.2. Polyclonal Antibody
16.19.3. Oligoclonal antibody
16.20. GCC Research Antibodies Market Forecast, By Antibody Clonality
16.20.1. Mouse
16.20.2. Rabbit
16.20.3. Others
16.21. GCC Research Antibodies Market Forecast, By Technology
16.21.1. Western Blotting
16.21.2. Flow Cytometry
16.21.3. Enzyme-linked Immunosorbent Assay
16.21.4. Immunohistochemistry
16.21.5. Immunofluorescence
16.21.6. Immunoprecipitation
16.21.7. Others
16.22. GCC Research Antibodies Market Forecast, By Application
16.22.1. Proteomics
16.22.2. Infectious Diseases
16.22.3. Immunology
16.22.4. Oncology
16.22.5. Stem Cells
16.22.6. Neurobiology
16.22.7. Others
16.23. GCC Research Antibodies Market Forecast, By End User
16.23.1. Pharmaceutical & Biotechnological Companies
16.23.2. Academic & Research Institutes
16.23.3. Contract Research Organizations
16.24. South Africa Research Antibodies Market Forecast, By Product type
16.24.1. Primary
16.24.2. Secondary
16.25. South Africa Research Antibodies Market Forecast, By Antibody Source
16.25.1. Monoclonal Antibody
16.25.2. Polyclonal Antibody
16.25.3. Oligoclonal antibody
16.26. South Africa Research Antibodies Market Forecast, By Antibody Clonality
16.26.1. Mouse
16.26.2. Rabbit
16.26.3. Others
16.27. South Africa Research Antibodies Market Forecast, By Technology
16.27.1. Western Blotting
16.27.2. Flow Cytometry
16.27.3. Enzyme-linked Immunosorbent Assay
16.27.4. Immunohistochemistry
16.27.5. Immunofluorescence
16.27.6. Immunoprecipitation
16.27.7. Others
16.28. South Africa Research Antibodies Market Forecast, By Application
16.28.1. Proteomics
16.28.2. Infectious Diseases
16.28.3. Immunology
16.28.4. Oncology
16.28.5. Stem Cells
16.28.6. Neurobiology
16.28.7. Others
16.29. South Africa Research Antibodies Market Forecast, By End User
16.29.1. Pharmaceutical & Biotechnological Companies
16.29.2. Academic & Research Institutes
16.29.3. Contract Research Organizations
16.30. Rest of Middle East & Africa Research Antibodies Market Forecast, By Product type
16.30.1. Primary
16.30.2. Secondary
16.31. Rest of Middle East & Africa Research Antibodies Market Forecast, By Antibody Source
16.31.1. Monoclonal Antibody
16.31.2. Polyclonal Antibody
16.31.3. Oligoclonal antibody
16.32. Rest of Middle East & Africa Research Antibodies Market Forecast, By Antibody Clonality
16.32.1. Mouse
16.32.2. Rabbit
16.32.3. Others
16.33. Rest of Middle East & Africa Research Antibodies Market Forecast, By Technology
16.33.1. Western Blotting
16.33.2. Flow Cytometry
16.33.3. Enzyme-linked Immunosorbent Assay
16.33.4. Immunohistochemistry
16.33.5. Immunofluorescence
16.33.6. Immunoprecipitation
16.33.7. Others
16.34. Rest of Middle East & Africa Research Antibodies Market Forecast, By Application
16.34.1. Proteomics
16.34.2. Infectious Diseases
16.34.3. Immunology
16.34.4. Oncology
16.34.5. Stem Cells
16.34.6. Neurobiology
16.34.7. Others
16.35. Rest of Middle East & Africa Research Antibodies Market Forecast, By End User
16.35.1. Pharmaceutical & Biotechnological Companies
16.35.2. Academic & Research Institutes
16.35.3. Contract Research Organizations
16.36. Middle East & Africa Global Research Antibodies Market Attractiveness Analysis
16.36.1. By Product type
16.36.2. By Antibody Clonality
16.36.3. By Antibody Source
16.36.4. By Technology
16.36.5. By Application
16.36.6. By End User
16.37. PEST Analysis
17. Latin America Research Antibodies Market Analysis
17.1. Key Findings
17.2. Latin America Research Antibodies Market Overview
17.3. Latin America Research Antibodies Market Value Share Analysis, By Product type
17.4. Latin America Research Antibodies Market Forecast, By Product type
17.4.1. Primary
17.4.2. Secondary
17.5. Latin America Research Antibodies Market Value Share Analysis, By Antibody Source
17.6. Latin America Research Antibodies Market Forecast, By Antibody Source
17.6.1. Monoclonal Antibody
17.6.2. Polyclonal Antibody
17.6.3. Oligoclonal Antibody
17.7. Latin America Research Antibodies Market Value Share Analysis, By Antibody Clonality
17.8. Latin America Research Antibodies Market Forecast, By Antibody Clonality
17.8.1. Mouse
17.8.2. Rabbit
17.8.3. Others
17.9. Latin America Research Antibodies Market Value Share Analysis, By Technology
17.10. Latin America Research Antibodies Market Forecast, By Technology
17.10.1. Western Blotting
17.10.2. Flow Cytometry
17.10.3. Enzyme-linked Immunosorbent Assay
17.10.4. Immunohistochemistry
17.10.5. Immunofluorescence
17.10.6. Immunoprecipitation
17.10.7. Others
17.11. Latin America Research Antibodies Market Value Share Analysis, By Application
17.12. Latin America Research Antibodies Market Forecast, By Application
17.12.1. Proteomics
17.12.2. Infectious Diseases
17.12.3. Immunology
17.12.4. Oncology
17.12.5. Stem Cells
17.12.6. Neurobiology
17.12.7. Others
17.13. Latin America Research Antibodies Market Value Share Analysis, By End User
17.14. Latin America Research Antibodies Market Forecast, By End User
17.14.1. Pharmaceutical & Biotechnological Companies
17.14.2. Academic & Research Institutes
17.14.3. Contract Research Organizations
17.15. Latin America Research Antibodies Market Value Share Analysis, By Country
17.16. Latin America Research Antibodies Market Forecast, By Country
17.16.1.1. Brazil.
17.16.1.2. Mexico.
17.16.1.3. Rest of Latin America.
17.17. Latin America Research Antibodies Market Analysis, By Country/ Sub-region
17.18. Brazil Research Antibodies Market Forecast, By Product type
17.18.1. Primary
17.18.2. Secondary
17.19. Brazil Research Antibodies Market Forecast, By Antibody Source
17.19.1. Monoclonal Antibody
17.19.2. Polyclonal Antibody
17.19.3. Oligoclonal antibody
17.20. Brazil Research Antibodies Market Forecast, By Antibody Clonality
17.20.1. Mouse
17.20.2. Rabbit
17.20.3. Others
17.21. Brazil Research Antibodies Market Forecast, By Technology
17.21.1. Western Blotting
17.21.2. Flow Cytometry
17.21.3. Enzyme-linked Immunosorbent Assay
17.21.4. Immunohistochemistry
17.21.5. Immunofluorescence
17.21.6. Immunoprecipitation
17.21.7. Others
17.22. Brazil Research Antibodies Market Forecast, By Application
17.22.1. Proteomics
17.22.2. Infectious Diseases
17.22.3. Immunology
17.22.4. Oncology
17.22.5. Stem Cells
17.22.6. Neurobiology
17.22.7. Others
17.23. Brazil Research Antibodies Market Forecast, By End User
17.23.1. Pharmaceutical & Biotechnological Companies
17.23.2. Academic & Research Institutes
17.23.3. Contract Research Organizations
17.24. Mexico Research Antibodies Market Forecast, By Product type
17.24.1. Primary
17.24.2. Secondary
17.25. Mexico Research Antibodies Market Forecast, By Antibody Source
17.25.1. Monoclonal Antibody
17.25.2. Polyclonal Antibody
17.25.3. Oligoclonal antibody
17.26. Mexico Research Antibodies Market Forecast, By Antibody Clonality
17.26.1. Mouse
17.26.2. Rabbit
17.26.3. Others
17.27. Mexico Research Antibodies Market Forecast, By Technology
17.27.1. Western Blotting
17.27.2. Flow Cytometry
17.27.3. Enzyme-linked Immunosorbent Assay
17.27.4. Immunohistochemistry
17.27.5. Immunofluorescence
17.27.6. Immunoprecipitation
17.27.7. Others
17.28. Mexico Research Antibodies Market Forecast, By Application
17.28.1. Proteomics
17.28.2. Infectious Diseases
17.28.3. Immunology
17.28.4. Oncology
17.28.5. Stem Cells
17.28.6. Neurobiology
17.28.7. Others
17.29. Mexico Research Antibodies Market Forecast, By End User
17.29.1. Pharmaceutical & Biotechnological Companies
17.29.2. Academic & Research Institutes
17.29.3. Contract Research Organizations
17.30. Rest of Latin America Research Antibodies Market Forecast, By Product type
17.30.1. Primary
17.30.2. Secondary
17.31. Rest of Latin America Research Antibodies Market Forecast, By Antibody Source
17.31.1. Monoclonal Antibody
17.31.2. Polyclonal Antibody
17.31.3. Oligoclonal antibody
17.32. Rest of Latin America Research Antibodies Market Forecast, By Antibody Clonality
17.32.1. Mouse
17.32.2. Rabbit
17.32.3. Others
17.33. Rest of Latin America Research Antibodies Market Forecast, By Technology
17.33.1. Western Blotting
17.33.2. Flow Cytometry
17.33.3. Enzyme-linked Immunosorbent Assay
17.33.4. Immunohistochemistry
17.33.5. Immunofluorescence
17.33.6. Immunoprecipitation
17.33.7. Others
17.34. Rest of Latin America Research Antibodies Market Forecast, By Application
17.34.1. Proteomics
17.34.2. Infectious Diseases
17.34.3. Immunology
17.34.4. Oncology
17.34.5. Stem Cells
17.34.6. Neurobiology
17.34.7. Others
17.35. Rest of Latin America Research Antibodies Market Forecast, By End User
17.35.1. Pharmaceutical & Biotechnological Companies
17.35.2. Academic & Research Institutes
17.35.3. Contract Research Organizations Latin
17.36. Latin America Global Research Antibodies Market Attractiveness Analysis
17.36.1. By Product type
17.36.2. By Antibody Clonality
17.36.3. By Antibody Source
17.36.4. By Technology
17.36.5. By Application
17.36.6. By End User
17.37. PEST Analysis
18. Company Profiles
18.1. Market Share Analysis, By Company
18.2. Competition Matrix
18.3. Company Profiles: Key Player
18.3.1. Abcam PLC
18.3.1.1. Company Overview
18.3.1.2. Financial Overview
18.3.1.3. Business Strategy
18.3.1.4. Recent Developments
18.3.1.5. Manufacturing Footprint
18.3.2. Active Motif
18.3.3. Affinity Biologicals Inc.
18.3.4. Becton Dickinson and Company
18.3.5. Bethyl Laboratories Inc.
18.3.6. Biolegend Inc.
18.3.7. Bio-Rad Laboratories Inc.
18.3.8. Cell Signaling Technology Inc.
18.3.9. Danaher Corporation
18.3.10. Enzo Life Sciences Inc.
18.3.11. F. Hoffmann-La Roche Ltd
18.3.12. Genscript
18.3.13. Jackson Immunoresearch Inc.
18.3.14. Lonza
18.3.15. Merck Group
18.3.16. Miltenyl Biotec
18.3.17. Origene Technologies Inc.
18.3.18. Perkinelmer Inc.
18.3.19. Qiagen N.V.
18.3.20. Rockland Immunochemicals Inc.
18.3.21. Sysmex Corporation
18.3.22. Thermo Fisher Scientific Inc.
19. Primary Key Insights
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
Best quality reports based on various authentic and accurate data findings.
Your personal and confidential information is safe and secure.
Trends Market Research © Copyright 2021. All Rights Reserved.